Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dasatinib (sprycel) (2 trials)
imatinib (gleevec) (1 trial)
Leukemia (Phase 2)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Trials (2 total)
Trial APIs (2 total)